KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Sales (2016 - 2025)

Historic Return on Sales for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 0.09%.

  • Bristol Myers Squibb's Return on Sales rose 800.0% to 0.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.15%, marking a year-over-year increase of 3300.0%. This contributed to the annual value of 0.15% for FY2025, which is 3300.0% up from last year.
  • Bristol Myers Squibb's Return on Sales amounted to 0.09% in Q4 2025, which was up 800.0% from 0.18% recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Return on Sales high stood at 0.22% for Q1 2025, and its period low was 1.0% during Q1 2024.
  • Its 5-year average for Return on Sales is 0.09%, with a median of 0.14% in 2022.
  • As far as peak fluctuations go, Bristol Myers Squibb's Return on Sales tumbled by -12000bps in 2024, and later skyrocketed by 12200bps in 2025.
  • Bristol Myers Squibb's Return on Sales (Quarter) stood at 0.2% in 2021, then dropped by -10bps to 0.18% in 2022, then fell by -14bps to 0.15% in 2023, then crashed by -96bps to 0.01% in 2024, then soared by 1311bps to 0.09% in 2025.
  • Its Return on Sales stands at 0.09% for Q4 2025, versus 0.18% for Q3 2025 and 0.11% for Q2 2025.